Comfort Systems USA Inc vs Pfizer Inc — how do they compare? Comfort Systems USA Inc trades at $1,715.69 (market cap $60.06B), while Pfizer Inc trades at $28.28 (market cap $158.56B). The key difference: Pfizer Inc is far larger — about 2.6× Comfort Systems USA Inc's market cap, and Pfizer Inc pays the higher dividend (6.18%). Which is the better fit depends on your goals — on Pluang, investors hold Comfort Systems USA Inc for 41 Days and Pfizer Inc for 158 Days on average.
| FIX | PFE | |
|---|---|---|
Market Cap | $60.06B | $158.56B |
Volume | 371,896 | 44,138,282 |
Sector | Industrials | Health |
52-Week High | $2.07K | $29.02 |
52-Week Low | $790.72 | $23.67 |
Typical Hold Time | 41 Days | 158 Days |
Enterprise Value | $58.53B | $210.06B |
Dividend Yield | 0.21% | 6.18% |
Signals from Pluang's Aura AI — not financial advice
Comfort Systems USA (FIX) trades at $1,715.69, down 1.47% over 24 hours. The stock exhibits a bullish technical signal with strong moving averages, while oscillators are neutral. Fundamentally, the company shows robust growth with revenue rising to $11.2B in 2026 and net income reaching $1.4B, supported by consistent earnings beats. Recent news highlights its strategic positioning in data center and infrastructure projects, including the acquisition of Hunt Electric.
The outlook remains positive given strong analyst consensus (55.56% buy ratings) and a price target of $2,080. Key risks include execution challenges in project estimates and macroeconomic sensitivity. The stock presents a growth opportunity driven by AI infrastructure demand, but investors should monitor backlog conversion and competitive pressures.
Pfizer (PFE) trades at $27.82, down 0.64% on the day, with a bullish technical signal from moving averages and oversold RSI levels. The company reported revenue of $62.58B in 2025 with a net income margin of 6.8%, and has beaten earnings estimates for three consecutive quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline, positioning for a catalyst-rich 2026.
The stock presents a value opportunity with a forward P/E of 36.61 and consensus price target of $29.17, but faces risks from patent cliffs and volatile cash flows. Analyst sentiment is mixed with 40% buy ratings, while institutional outlook remains cautious amid earnings pressure and competitive threats in the pharma sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Comfort Systems USA is a premier provider of mechanical and electrical contracting services. It specializes in HVAC, plumbing, and energy management solutions for commercial and industrial facilities.
Read more on FIX →Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →